Tonghua Dongbao Pharmaceutical Co Ltd (600867) — Financial Flexibility Index
Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Financial Flexibility Index of 0.21x as of September 2025. Free cash flow of CN¥213.57 Million (operating CF CN¥62.99 Million minus capex CN¥150.58 Million) represents 0% of total liabilities (CN¥1.02 Billion). Check 600867 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tonghua Dongbao Pharmaceutical Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Tonghua Dongbao Pharmaceutical Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see Tonghua Dongbao Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Tonghua Dongbao Pharmaceutical Co Ltd. Explore 600867 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.51x | CN¥1.21 Billion | CN¥689.23 Million | CN¥798.84 Million | ▲ +43.7% |
| 2024 | 1.05x | CN¥1.03 Billion | CN¥459.74 Million | CN¥978.08 Million | ▼ -51.7% |
| 2023 | 2.18x | CN¥1.21 Billion | CN¥861.52 Million | CN¥555.08 Million | ▼ -67.7% |
| 2022 | 6.75x | CN¥1.35 Billion | CN¥863.09 Million | CN¥200.74 Million | ▲ +16.6% |
| 2021 | 5.79x | CN¥1.74 Billion | CN¥1.13 Billion | CN¥299.87 Million | ▼ -15.6% |
| 2020 | 6.86x | CN¥1.67 Billion | CN¥1.19 Billion | CN¥243.80 Million | ▲ +61.8% |
| 2019 | 4.24x | CN¥1.45 Billion | CN¥1.15 Billion | CN¥341.10 Million | ▲ +87.2% |
| 2018 | 2.26x | CN¥1.65 Billion | CN¥876.94 Million | CN¥729.06 Million | ▼ -57.5% |
| 2017 | 5.33x | CN¥1.15 Billion | CN¥961.19 Million | CN¥215.30 Million | ▲ +241.8% |
| 2016 | 1.56x | CN¥1.14 Billion | CN¥725.76 Million | CN¥729.76 Million | ▲ +193.7% |
| 2015 | 0.53x | CN¥694.67 Million | CN¥294.58 Million | CN¥1.31 Billion | ▲ +35.3% |
| 2014 | 0.39x | CN¥311.97 Million | CN¥205.89 Million | CN¥795.72 Million | ▼ -35.4% |
| 2013 | 0.61x | CN¥411.41 Million | CN¥221.06 Million | CN¥678.23 Million | ▼ -45.9% |
| 2012 | 1.12x | CN¥436.15 Million | CN¥194.32 Million | CN¥388.92 Million | ▲ +894.5% |
| 2011 | 0.11x | CN¥33.76 Million | CN¥-55.07 Million | CN¥299.37 Million | ▼ -78.0% |
| 2010 | 0.51x | CN¥233.05 Million | CN¥160.40 Million | CN¥453.75 Million | ▲ +30.8% |
| 2009 | 0.39x | CN¥245.27 Million | CN¥166.20 Million | CN¥624.75 Million | ▲ +94.4% |
| 2008 | 0.20x | CN¥148.98 Million | CN¥92.31 Million | CN¥737.66 Million | ▼ -60.9% |
| 2007 | 0.52x | CN¥379.28 Million | CN¥120.94 Million | CN¥734.97 Million | ▼ -19.8% |
| 2006 | 0.64x | CN¥444.90 Million | CN¥158.00 Million | CN¥691.13 Million | ▲ +65.6% |
| 2005 | 0.39x | CN¥211.61 Million | CN¥92.23 Million | CN¥544.23 Million | ▲ +199.9% |
| 2004 | 0.13x | CN¥62.24 Million | CN¥13.17 Million | CN¥480.12 Million | ▼ -50.6% |
| 2003 | 0.26x | CN¥103.40 Million | CN¥45.51 Million | CN¥393.95 Million | ▼ -55.6% |
| 2002 | 0.59x | CN¥121.41 Million | CN¥31.99 Million | CN¥205.52 Million | ▼ -77.7% |
| 2001 | 2.65x | CN¥206.42 Million | CN¥117.73 Million | CN¥77.96 Million | ▲ +43.1% |
| 2000 | 1.85x | CN¥81.58 Million | CN¥29.12 Million | CN¥44.10 Million | ▲ +17.6% |
| 1999 | 1.57x | CN¥145.90 Million | CN¥-95.09 Million | CN¥92.79 Million | ▲ +295.9% |
| 1998 | -0.80x | CN¥-200.49 Million | CN¥-216.98 Million | CN¥249.82 Million | — |